The customer reported that pt occlusion alarms had occurred during cycle 1, just before the buffy collect phase.The customer paused the treatment and added "activase" to the pt's access device.When the customer resumed the treatment, a blood leak alarm occurred.The customer stated that no blood leak was visible in the centrifuge, but condensation was visible under the centrifuge lid.The customer stated that the centrifuge bowl had been spinning while the treatment was paused.The clinical services specialist (css) advised the customer that therakos recommends the treatment be aborted without returning the blood from the kit to the pt if a leak is suspected.The css advised the customer to consult the attending physician.The customer indicated that the treatment would be aborted as recommended, without returning any blood to the pt.The pt was reported to be in stable condition.No service order was generated.The kit was not returned for eval.
|
A batch record review of lot c742 was conducted.There were no nonconformities related to the complaint.The lot met release requirements.Trends were reviewed for complaint categories occlusion pt alarm and centrifuge bowl leak/break.No trend was detected for these complaint categories.No capa was initiated for complaint categories, occlusion pt alarm and centrifuge bowl leak/break.The assessment is based on info available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the info provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).
|